搜索结果31-40 的 28296 / Gene therapy

  1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The purpose of this Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in ...

  2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The purpose of this Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in ...

  3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Guidance for molecular targeted therapy will involve gene analysis of oncogenes and tumor suppressor genes. Results from these studies may provide the rationale ...

  4. 血液科- 临床试验- 妙佑医疗国际

    CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/​Refractory B Cell Malignancies ... This gene allows the T cells to recognize and possibly treat ...

  5. 血液科- 临床试验- 妙佑医疗国际

    CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/​Refractory B Cell Malignancies ... This gene allows the T cells to recognize and possibly treat ...

  6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The purpose of this Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in ...

  7. 长 QT 综合征- 医生与科室- 妙佑医疗国际

    Science Saturday: Novel suppression-replacement preclinical gene therapy study shows promise in long and short QT syndromes Nov. 19, 2022, 12:00 p.m. CDT; 崭 ...

  8. 核医学疗法- 临床试验- 妙佑医疗国际

    ... Therapy (PRRT dose)) with genetic and clonal abnormalities (blood-based CHIP panel) in studying the predisposing risk factors for developing hematological ...

  9. 血液科- 临床试验- 妙佑医疗国际

    CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/​Refractory B Cell Malignancies ... This gene allows the T cells to recognize and possibly treat ...

  10. 长 QT 综合征- 医生与科室- 妙佑医疗国际

    Mayo Clinic 新闻. Science Saturday: Novel suppression-replacement preclinical gene therapy study shows promise in long and short QT syndromes Nov. 19, 2022 ...